Cargando…

miR-27a-3p regulates the inhibitory influence of endothelin 3 on the tumorigenesis of papillary thyroid cancer cells

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Chen, Hongxin, Cai, Binlin, Liu, Kun, Hua, Qingquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097749/ https://www.ncbi.nlm.nih.gov/pubmed/33880586 http://dx.doi.org/10.3892/mmr.2021.12105

Ejemplares similares

miR-27a-3p regulates the inhibitory influence of endothelin 3 on the tumorigenesis of papillary thyroid cancer cells
por: Chen, Hongxin, et al.
Publicado: (2021)

Downregulation of miR-575 Inhibits the Tumorigenesis of Gallbladder Cancer via Targeting P27 Kip1 [Corrigendum]
Publicado: (2020)

Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis [Corrigendum]
Publicado: (2017)

The targeting of MTDH by miR-145-5p or miR-145-3p is associated with prognosis and regulates the growth and metastasis of prostate cancer cells
por: Pan, Dong, et al.
Publicado: (2023)

miR-29a inhibits human retinoblastoma progression by targeting STAT3
por: Liu, Shu, et al.
Publicado: (2021)

Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion
por: Wang, Yu, et al.
Publicado: (2023)

[Corrigendum] Downregulation of miR‑637 promotes proliferation and metastasis by targeting Smad3 in keloids
por: Zhang, Ye, et al.
Publicado: (2023)

MiR-345-5p inhibits tumorigenesis of papillary thyroid carcinoma by targeting SETD7
por: Zhao, Ming, et al.
Publicado: (2019)

Unraveling the Roles of miR-204-5p and HMGA2 in Papillary Thyroid Cancer Tumorigenesis
por: Van Branteghem, Cindy, et al.
Publicado: (2023)

CircPTPRM accelerates malignancy of papillary thyroid cancer via miR‐885‐5p/DNMT3A axis
por: Chen, Daping, et al.
Publicado: (2022)

miR-26a and its Target CKS2 Modulate Cell Growth and Tumorigenesis of Papillary Thyroid Carcinoma
por: Lv, Mingli, et al.
Publicado: (2013)

miR-500a-3p is a Potential Prognostic Biomarker in Hepatocellular Carcinoma [Corrigendum]
Publicado: (2022)

Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation
por: Zhou, Xin, et al.
Publicado: (2022)

Long Noncoding RNA H19 Facilitates Small Cell Lung Cancer Tumorigenesis Through miR-140-5p/FGF9 Axis [Corrigendum]
Publicado: (2020)

MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression
por: Fan, Z, et al.
Publicado: (2016)

TUSC8 inhibits the development of osteosarcoma by sponging miR-197-3p and targeting EHD2
por: Fan, Hongwu, et al.
Publicado: (2021)

miR-182-5p contributes to radioresistance in naso-pharyngeal carcinoma by regulating BNIP3 expression
por: He, Wei, et al.
Publicado: (2021)

Dendritic cell-derived exosomal miR-494-3p promotes angiogenesis following myocardial infarction
por: Liu, Haibo, et al.
Publicado: (2022)

miR-647 and miR-1914 promote cancer progression equivalently by downregulating nuclear factor IX in colorectal cancer
por: Liu, Shaoqing, et al.
Publicado: (2022)

Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid Microcarcinoma
por: Jeon, Min Ji, et al.
Publicado: (2022)

High glucose promotes hepatic fibrosis via miR-32/MTA3-mediated epithelial-to-mesenchymal transition
por: Li, Qiang, et al.
Publicado: (2022)

[Corrigendum] miR‑1299/NOTCH3/TUG1 feedback loop contributes to the malignant proliferation of ovarian cancer
por: Pei, Yuqing, et al.
Publicado: (2023)

LncRNA‐HOTAIR promotes endothelial cell pyroptosis by regulating the miR‐22/NLRP3 axis in hyperuricemia
Publicado: (2023)

miR-122 promotes proliferation and invasion of clear cell renal cell carcinoma by suppressing Forkhead box O3
por: Nie, Wenyuan, et al.
Publicado: (2019)

miR-195-Sirt3 Axis Regulates Angiotensin II-Induced Hippocampal Apoptosis and Learning Impairment in Mice [Corrigendum]
Publicado: (2021)

Corrigendum to “LncRNA SNHG3 Promotes Gastric Cancer Cells Proliferation, Migration, and Invasion by Targeting miR-326”
por: Rao, Jun, et al.
Publicado: (2022)

miR-140-3p Suppresses Cell Growth and Induces Apoptosis in Colorectal Cancer by Targeting PD-L1 [Corrigendum]
Publicado: (2020)

miR–9-5p regulates immunometabolic and epigenetic pathways in β-glucan–trained immunity via IDH3α
por: Su, Haibo, et al.
Publicado: (2022)

Addition of funding statement: Clinical characteristics of papillary thyroid carcinoma arising from the pyramidal lobe
por: Yoon, Sang Gab, et al.
Publicado: (2017)

Corrigendum to “miR-331-3p Inhibits Proliferation and Promotes Apoptosis of Nasopharyngeal Carcinoma Cells by Targeting elf4B-PI3K-AKT Pathway”
Publicado: (2020)

Corrigendum to: LMTK3 promotes tumorigenesis in bladder cancer via the ERK/MAPK pathway
Publicado: (2021)

CircBCAR3 accelerates esophageal cancer tumorigenesis and metastasis via sponging miR-27a-3p
por: Xi, Yong, et al.
Publicado: (2022)

miR-218 overexpression suppresses tumorigenesis of papillary thyroid cancer via inactivation of PTEN/PI3K/AKT pathway by targeting Runx2
por: Han, Mingkun, et al.
Publicado: (2018)

SNHG15 affects the growth of glioma microvascular endothelial cells by negatively regulating miR-153
por: Ma, Yawen, et al.
Publicado: (2022)

miR-505 suppresses prostate cancer progression by targeting NRCAM
por: Ling, Xiao-Hui, et al.
Publicado: (2020)

Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma
por: Li, Min, et al.
Publicado: (2015)

Corrigendum to “miR-221 Alleviates the Ox-LDL-Induced Macrophage Inflammatory Response via the Inhibition of DNMT3b-Mediated NCoR Promoter Methylation”
por: Ye, Jinshan, et al.
Publicado: (2020)

Retraction: miR-26a and its Target CKS2 Modulate Cell Growth and Tumorigenesis of Papillary Thyroid Carcinoma
Publicado: (2021)

MiR-495-3p regulates cell migration and invasion in papillary thyroid carcinoma
por: Alves, Letícia Ferreira, et al.
Publicado: (2023)

miR-30d inhibits cell biological progression of Ewing's sarcoma by suppressing the MEK/ERK and PI3K/Akt pathways in vitro
por: Ye, Conglin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fa35i1ptrriju53d198co3u4v3